⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

April 5, 2021JAMA

Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines

Johanna Chapin-Bardales Julianne Gee Tanya R. Myers

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research aims to investigate the reactogenicity of mRNA-based COVID-19 vaccines and identify factors influencing immune response.
Study design assessing vaccine reactogenicity among varied populations.
Participants received mRNA vaccines and reported adverse events following immunization.
Data on immune response was collected and analyzed.
High rates of mild to moderate reactogenicity observed, with younger individuals reporting more adverse events.
Reactogenicity correlates with immune response levels, showing significant variation across demographics.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Evaluates reactogenicity of mRNA COVID-19 vaccines in diverse populations, suggesting variability in immune responses.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chapin-Bardales et al. (2021) studied this question.

synapsesocial.com/papers/6a3b1eb6cc8dbc104a21ba9a https://doi.org/10.1001/jama.2021.5374

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1P-1446. Durable RSV-Specific CD4⁺ T-Cell Responses Following mRNA-1345 Vaccination in Adults at Increased Risk of Lower Respiratory Tract Disease Due to RSVLate-Phase Clinical Trial · 2026 · 1 citations
2P-1657. Difference in reactogenicity events between mRNA and Protein-subunit Vaccines: Results from the Booster Epidemiological Evaluation of Health, Illness, and Vaccine Efficacy (BEEHIVE) Study, a U.S. randomized trial of 2023-2024 COVID-19 vaccines (XBB.1.5)Randomized Controlled Trial · 2026
3Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines2024 · 11 citations
4P-1447. T-Cell Responses Following Two Doses of mRNA-1345 in Adult Solid Organ Transplant RecipientsLate-Phase Clinical Trial · 2026
5Reactogenicity Differences between COVID-19 Vaccines: A Prospective Observational Study in the United States and Canada2024 · 11 citations
6Temporal Associations Between Immunization With the COVID-19 mRNA Vaccines and MyocarditisOriginal Research · 2021 · 11 citations
7Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health SystemCase Report · 2021 · 135 citations
8Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccineseditorial · 2021 · 114 citations
9Think Outside the Box With Intravenous Iron—The New Ferric Carboxymaltose FDA Boxed WarningJAMA · 2026
10Loberamisal for Acute Ischemic StrokeJAMA · 2026

More from CDC Foundation